Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Back to Journals Drug Design, Development and Therapy Volume 19 The Role of Radiosensitizing Drugs in Osteosarcoma Treatment: Mechanisms and Clinical Perspectives Authors Zhang Y, Xie Y, Wang Y, Huang P, Lu Y Received 16 December 2024 Accepted for publication 9 March 2025 Published 14 March 2025 Volume 2025:19 Pages 19271942 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Muzammal Hussain Yilei Zhang, * Yuhuan Xie, * Yiwen Wang, * Panpan Huang, Yao Lu School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, Peoples Republic of China *These authors contributed equally to this work Correspondence: Yao Lu
Compared to cosmetic peptides like GHK-Cu or Matrixyl, TB-500 is considered more advanced and is typically discussed in clinical or recovery-focused settings rather than daily skincare routines
What does KLOW stand for
Most people who need hemodialysis suffer from a range of medical conditions
Its time-consuming protocols for image acquisition makes DCE-MRI still not part of the routine clinical practice (169, 170)
US$ 27.44
US$ 24.50
US$ 22.60
US$ 26.61
